nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—ORM1—Vemurafenib—melanoma	0.141	0.223	CbGbCtD
Quinidine—ABCB1—melanoma	0.101	1	CbGaD
Quinidine—SLC22A5—Dactinomycin—melanoma	0.0814	0.128	CbGbCtD
Quinidine—CYP1A1—Dacarbazine—melanoma	0.061	0.0961	CbGbCtD
Quinidine—CYP2E1—Dacarbazine—melanoma	0.0471	0.0742	CbGbCtD
Quinidine—CYP1A2—Carmustine—melanoma	0.045	0.0709	CbGbCtD
Quinidine—CYP1A2—Vemurafenib—melanoma	0.0355	0.056	CbGbCtD
Quinidine—CYP3A4—Temozolomide—melanoma	0.034	0.0536	CbGbCtD
Quinidine—ABCC2—Docetaxel—melanoma	0.0327	0.0516	CbGbCtD
Quinidine—CYP2D6—Vemurafenib—melanoma	0.0293	0.0462	CbGbCtD
Quinidine—CYP1A2—Dacarbazine—melanoma	0.0272	0.0429	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0218	0.0344	CbGbCtD
Quinidine—CYP3A7—Docetaxel—melanoma	0.0218	0.0344	CbGbCtD
Quinidine—ABCB1—Dactinomycin—melanoma	0.0206	0.0326	CbGbCtD
Quinidine—CYP3A4—Vemurafenib—melanoma	0.0186	0.0293	CbGbCtD
Quinidine—ABCB1—Docetaxel—melanoma	0.0107	0.0168	CbGbCtD
Quinidine—CYP3A4—Docetaxel—melanoma	0.00639	0.0101	CbGbCtD
Quinidine—SLC22A8—optic choroid—melanoma	0.000634	0.141	CbGeAlD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000615	0.00465	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000614	0.00464	CcSEcCtD
Quinidine—Oliguria—Docetaxel—melanoma	0.000613	0.00464	CcSEcCtD
Quinidine—Pancytopenia—Bleomycin—melanoma	0.0006	0.00454	CcSEcCtD
Quinidine—Ataxia—Carmustine—melanoma	0.0006	0.00454	CcSEcCtD
Quinidine—Hearing impaired—Docetaxel—melanoma	0.000594	0.00449	CcSEcCtD
Quinidine—Liver function test abnormal—Carmustine—melanoma	0.00059	0.00446	CcSEcCtD
Quinidine—Nervous system disorder—Vemurafenib—melanoma	0.000582	0.0044	CcSEcCtD
Quinidine—Ataxia—Temozolomide—melanoma	0.00058	0.00439	CcSEcCtD
Quinidine—Skin disorder—Vemurafenib—melanoma	0.000576	0.00436	CcSEcCtD
Quinidine—Muscular weakness—Carmustine—melanoma	0.000563	0.00426	CcSEcCtD
Quinidine—Pancytopenia—Dactinomycin—melanoma	0.00056	0.00423	CcSEcCtD
Quinidine—Breast disorder—Temozolomide—melanoma	0.000558	0.00421	CcSEcCtD
Quinidine—KCNK1—hair follicle—melanoma	0.000557	0.124	CbGeAlD
Quinidine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000556	0.0042	CcSEcCtD
Quinidine—Hypotension—Vemurafenib—melanoma	0.000555	0.00419	CcSEcCtD
Quinidine—Neutropenia—Dactinomycin—melanoma	0.000551	0.00417	CcSEcCtD
Quinidine—Muscular weakness—Temozolomide—melanoma	0.000544	0.00411	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000541	0.00409	CcSEcCtD
Quinidine—Pancytopenia—Carmustine—melanoma	0.000524	0.00396	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000521	0.00394	CcSEcCtD
Quinidine—Oesophagitis—Docetaxel—melanoma	0.000517	0.0039	CcSEcCtD
Quinidine—Neutropenia—Carmustine—melanoma	0.000516	0.0039	CcSEcCtD
Quinidine—Decreased appetite—Vemurafenib—melanoma	0.000516	0.0039	CcSEcCtD
Quinidine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000512	0.00387	CcSEcCtD
Quinidine—Haemoglobin—Bleomycin—melanoma	0.000509	0.00384	CcSEcCtD
Quinidine—Pancytopenia—Temozolomide—melanoma	0.000506	0.00383	CcSEcCtD
Quinidine—Haemorrhage—Bleomycin—melanoma	0.000506	0.00382	CcSEcCtD
Quinidine—Pulmonary oedema—Docetaxel—melanoma	0.000503	0.0038	CcSEcCtD
Quinidine—Neutropenia—Temozolomide—melanoma	0.000499	0.00377	CcSEcCtD
Quinidine—Agranulocytosis—Dactinomycin—melanoma	0.000491	0.00371	CcSEcCtD
Quinidine—Photosensitivity reaction—Temozolomide—melanoma	0.000487	0.00368	CcSEcCtD
Quinidine—Renal failure—Carmustine—melanoma	0.000484	0.00366	CcSEcCtD
Quinidine—Hepatitis—Dactinomycin—melanoma	0.000472	0.00357	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000471	0.00356	CcSEcCtD
Quinidine—Flushing—Bleomycin—melanoma	0.00047	0.00355	CcSEcCtD
Quinidine—Body temperature increased—Vemurafenib—melanoma	0.000469	0.00355	CcSEcCtD
Quinidine—Deafness—Docetaxel—melanoma	0.000459	0.00347	CcSEcCtD
Quinidine—Chills—Bleomycin—melanoma	0.000454	0.00343	CcSEcCtD
Quinidine—Erythema multiforme—Dactinomycin—melanoma	0.000446	0.00337	CcSEcCtD
Quinidine—Haemoglobin—Carmustine—melanoma	0.000444	0.00336	CcSEcCtD
Quinidine—Haemorrhage—Carmustine—melanoma	0.000442	0.00334	CcSEcCtD
Quinidine—Erythema—Bleomycin—melanoma	0.000441	0.00333	CcSEcCtD
Quinidine—Flushing—Dactinomycin—melanoma	0.000438	0.00331	CcSEcCtD
Quinidine—Hypersensitivity—Vemurafenib—melanoma	0.000437	0.0033	CcSEcCtD
Quinidine—Visual disturbance—Docetaxel—melanoma	0.000433	0.00327	CcSEcCtD
Quinidine—Renal impairment—Docetaxel—melanoma	0.000431	0.00326	CcSEcCtD
Quinidine—Dermatitis bullous—Docetaxel—melanoma	0.000429	0.00324	CcSEcCtD
Quinidine—Haemoglobin—Temozolomide—melanoma	0.000429	0.00324	CcSEcCtD
Quinidine—Haemorrhage—Temozolomide—melanoma	0.000427	0.00323	CcSEcCtD
Quinidine—Hepatitis—Temozolomide—melanoma	0.000427	0.00323	CcSEcCtD
Quinidine—Asthenia—Vemurafenib—melanoma	0.000426	0.00322	CcSEcCtD
Quinidine—Visual impairment—Carmustine—melanoma	0.000426	0.00322	CcSEcCtD
Quinidine—Chills—Dactinomycin—melanoma	0.000423	0.0032	CcSEcCtD
Quinidine—Urinary tract disorder—Temozolomide—melanoma	0.000422	0.00319	CcSEcCtD
Quinidine—Pruritus—Vemurafenib—melanoma	0.00042	0.00317	CcSEcCtD
Quinidine—Urethral disorder—Temozolomide—melanoma	0.000418	0.00316	CcSEcCtD
Quinidine—Eye disorder—Carmustine—melanoma	0.000413	0.00312	CcSEcCtD
Quinidine—Visual impairment—Temozolomide—melanoma	0.000411	0.00311	CcSEcCtD
Quinidine—Erythema—Dactinomycin—melanoma	0.000411	0.00311	CcSEcCtD
Quinidine—Flushing—Carmustine—melanoma	0.00041	0.0031	CcSEcCtD
Quinidine—Diarrhoea—Vemurafenib—melanoma	0.000406	0.00307	CcSEcCtD
Quinidine—Erythema multiforme—Temozolomide—melanoma	0.000404	0.00305	CcSEcCtD
Quinidine—Eye disorder—Temozolomide—melanoma	0.000399	0.00302	CcSEcCtD
Quinidine—Tinnitus—Temozolomide—melanoma	0.000398	0.00301	CcSEcCtD
Quinidine—Cardiac disorder—Temozolomide—melanoma	0.000396	0.00299	CcSEcCtD
Quinidine—Flushing—Temozolomide—melanoma	0.000396	0.00299	CcSEcCtD
Quinidine—Leukopenia—Bleomycin—melanoma	0.000394	0.00298	CcSEcCtD
Quinidine—Dizziness—Vemurafenib—melanoma	0.000392	0.00297	CcSEcCtD
Quinidine—Mental disorder—Carmustine—melanoma	0.000387	0.00292	CcSEcCtD
Quinidine—Ataxia—Docetaxel—melanoma	0.000386	0.00292	CcSEcCtD
Quinidine—Immune system disorder—Temozolomide—melanoma	0.000386	0.00291	CcSEcCtD
Quinidine—Mediastinal disorder—Temozolomide—melanoma	0.000385	0.00291	CcSEcCtD
Quinidine—Erythema—Carmustine—melanoma	0.000385	0.00291	CcSEcCtD
Quinidine—Malnutrition—Carmustine—melanoma	0.000385	0.00291	CcSEcCtD
Quinidine—Chills—Temozolomide—melanoma	0.000383	0.00289	CcSEcCtD
Quinidine—Liver function test abnormal—Docetaxel—melanoma	0.000379	0.00286	CcSEcCtD
Quinidine—Vomiting—Vemurafenib—melanoma	0.000377	0.00285	CcSEcCtD
Quinidine—Chest pain—Bleomycin—melanoma	0.000375	0.00283	CcSEcCtD
Quinidine—Myalgia—Bleomycin—melanoma	0.000375	0.00283	CcSEcCtD
Quinidine—Orthostatic hypotension—Docetaxel—melanoma	0.000375	0.00283	CcSEcCtD
Quinidine—Abdominal pain upper—Docetaxel—melanoma	0.000375	0.00283	CcSEcCtD
Quinidine—Rash—Vemurafenib—melanoma	0.000374	0.00283	CcSEcCtD
Quinidine—Mental disorder—Temozolomide—melanoma	0.000374	0.00283	CcSEcCtD
Quinidine—Dermatitis—Vemurafenib—melanoma	0.000374	0.00283	CcSEcCtD
Quinidine—Headache—Vemurafenib—melanoma	0.000372	0.00281	CcSEcCtD
Quinidine—Erythema—Temozolomide—melanoma	0.000372	0.00281	CcSEcCtD
Quinidine—Malnutrition—Temozolomide—melanoma	0.000372	0.00281	CcSEcCtD
Quinidine—Breast disorder—Docetaxel—melanoma	0.000371	0.0028	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00037	0.00279	CcSEcCtD
Quinidine—Leukopenia—Dactinomycin—melanoma	0.000368	0.00278	CcSEcCtD
Quinidine—Confusional state—Bleomycin—melanoma	0.000363	0.00274	CcSEcCtD
Quinidine—Vision blurred—Carmustine—melanoma	0.000362	0.00274	CcSEcCtD
Quinidine—Tremor—Carmustine—melanoma	0.00036	0.00272	CcSEcCtD
Quinidine—Oedema—Bleomycin—melanoma	0.00036	0.00272	CcSEcCtD
Quinidine—KCNK6—head—melanoma	0.000356	0.079	CbGeAlD
Quinidine—Agitation—Carmustine—melanoma	0.000353	0.00267	CcSEcCtD
Quinidine—Nausea—Vemurafenib—melanoma	0.000352	0.00266	CcSEcCtD
Quinidine—Thrombocytopenia—Bleomycin—melanoma	0.000352	0.00266	CcSEcCtD
Quinidine—Vision blurred—Temozolomide—melanoma	0.00035	0.00265	CcSEcCtD
Quinidine—Myalgia—Dactinomycin—melanoma	0.00035	0.00264	CcSEcCtD
Quinidine—Bronchospasm—Docetaxel—melanoma	0.000349	0.00264	CcSEcCtD
Quinidine—Tremor—Temozolomide—melanoma	0.000348	0.00263	CcSEcCtD
Quinidine—Angina pectoris—Docetaxel—melanoma	0.000345	0.00261	CcSEcCtD
Quinidine—Leukopenia—Carmustine—melanoma	0.000344	0.0026	CcSEcCtD
Quinidine—Anorexia—Bleomycin—melanoma	0.000343	0.00259	CcSEcCtD
Quinidine—Agitation—Temozolomide—melanoma	0.000341	0.00258	CcSEcCtD
Quinidine—Angioedema—Temozolomide—melanoma	0.00034	0.00257	CcSEcCtD
Quinidine—Pancytopenia—Docetaxel—melanoma	0.000337	0.00255	CcSEcCtD
Quinidine—Hypotension—Bleomycin—melanoma	0.000336	0.00254	CcSEcCtD
Quinidine—Oedema—Dactinomycin—melanoma	0.000335	0.00253	CcSEcCtD
Quinidine—Vertigo—Temozolomide—melanoma	0.000334	0.00252	CcSEcCtD
Quinidine—Convulsion—Carmustine—melanoma	0.000333	0.00252	CcSEcCtD
Quinidine—Leukopenia—Temozolomide—melanoma	0.000333	0.00251	CcSEcCtD
Quinidine—Neutropenia—Docetaxel—melanoma	0.000332	0.00251	CcSEcCtD
Quinidine—Palpitations—Temozolomide—melanoma	0.000328	0.00248	CcSEcCtD
Quinidine—Thrombocytopenia—Dactinomycin—melanoma	0.000328	0.00248	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000328	0.00248	CcSEcCtD
Quinidine—Myalgia—Carmustine—melanoma	0.000327	0.00247	CcSEcCtD
Quinidine—Chest pain—Carmustine—melanoma	0.000327	0.00247	CcSEcCtD
Quinidine—Convulsion—Temozolomide—melanoma	0.000322	0.00243	CcSEcCtD
Quinidine—Dyspnoea—Bleomycin—melanoma	0.000321	0.00242	CcSEcCtD
Quinidine—Anorexia—Dactinomycin—melanoma	0.00032	0.00242	CcSEcCtD
Quinidine—Confusional state—Carmustine—melanoma	0.000316	0.00239	CcSEcCtD
Quinidine—Myalgia—Temozolomide—melanoma	0.000316	0.00239	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000314	0.00237	CcSEcCtD
Quinidine—Oedema—Carmustine—melanoma	0.000314	0.00237	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000314	0.00237	CcSEcCtD
Quinidine—Decreased appetite—Bleomycin—melanoma	0.000313	0.00236	CcSEcCtD
Quinidine—Renal failure—Docetaxel—melanoma	0.000311	0.00235	CcSEcCtD
Quinidine—Jaundice—Docetaxel—melanoma	0.000308	0.00233	CcSEcCtD
Quinidine—Thrombocytopenia—Carmustine—melanoma	0.000307	0.00232	CcSEcCtD
Quinidine—Tachycardia—Carmustine—melanoma	0.000306	0.00231	CcSEcCtD
Quinidine—Confusional state—Temozolomide—melanoma	0.000306	0.00231	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000305	0.00231	CcSEcCtD
Quinidine—Oedema—Temozolomide—melanoma	0.000303	0.00229	CcSEcCtD
Quinidine—Anorexia—Carmustine—melanoma	0.000299	0.00226	CcSEcCtD
Quinidine—Nervous system disorder—Temozolomide—melanoma	0.000297	0.00225	CcSEcCtD
Quinidine—Thrombocytopenia—Temozolomide—melanoma	0.000297	0.00224	CcSEcCtD
Quinidine—Feeling abnormal—Bleomycin—melanoma	0.000296	0.00224	CcSEcCtD
Quinidine—Agranulocytosis—Docetaxel—melanoma	0.000295	0.00223	CcSEcCtD
Quinidine—Skin disorder—Temozolomide—melanoma	0.000295	0.00223	CcSEcCtD
Quinidine—Hypotension—Carmustine—melanoma	0.000293	0.00222	CcSEcCtD
Quinidine—Hyperhidrosis—Temozolomide—melanoma	0.000293	0.00222	CcSEcCtD
Quinidine—Decreased appetite—Dactinomycin—melanoma	0.000291	0.0022	CcSEcCtD
Quinidine—Anorexia—Temozolomide—melanoma	0.000289	0.00218	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000286	0.00216	CcSEcCtD
Quinidine—Urticaria—Bleomycin—melanoma	0.000286	0.00216	CcSEcCtD
Quinidine—Haemoglobin—Docetaxel—melanoma	0.000285	0.00216	CcSEcCtD
Quinidine—Body temperature increased—Bleomycin—melanoma	0.000284	0.00215	CcSEcCtD
Quinidine—Haemorrhage—Docetaxel—melanoma	0.000284	0.00215	CcSEcCtD
Quinidine—Hepatitis—Docetaxel—melanoma	0.000284	0.00215	CcSEcCtD
Quinidine—Urinary tract disorder—Docetaxel—melanoma	0.00028	0.00212	CcSEcCtD
Quinidine—Dyspnoea—Carmustine—melanoma	0.00028	0.00211	CcSEcCtD
Quinidine—Urethral disorder—Docetaxel—melanoma	0.000278	0.0021	CcSEcCtD
Quinidine—Feeling abnormal—Dactinomycin—melanoma	0.000276	0.00209	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000276	0.00209	CcSEcCtD
Quinidine—Gastrointestinal pain—Dactinomycin—melanoma	0.000274	0.00207	CcSEcCtD
Quinidine—Visual impairment—Docetaxel—melanoma	0.000274	0.00207	CcSEcCtD
Quinidine—Decreased appetite—Carmustine—melanoma	0.000273	0.00206	CcSEcCtD
Quinidine—Gastrointestinal disorder—Carmustine—melanoma	0.000271	0.00205	CcSEcCtD
Quinidine—Dyspnoea—Temozolomide—melanoma	0.00027	0.00204	CcSEcCtD
Quinidine—Erythema multiforme—Docetaxel—melanoma	0.000268	0.00203	CcSEcCtD
Quinidine—Eye disorder—Docetaxel—melanoma	0.000265	0.00201	CcSEcCtD
Quinidine—Abdominal pain—Dactinomycin—melanoma	0.000265	0.002	CcSEcCtD
Quinidine—Body temperature increased—Dactinomycin—melanoma	0.000265	0.002	CcSEcCtD
Quinidine—Hypersensitivity—Bleomycin—melanoma	0.000265	0.002	CcSEcCtD
Quinidine—Decreased appetite—Temozolomide—melanoma	0.000264	0.00199	CcSEcCtD
Quinidine—Cardiac disorder—Docetaxel—melanoma	0.000263	0.00199	CcSEcCtD
Quinidine—Flushing—Docetaxel—melanoma	0.000263	0.00199	CcSEcCtD
Quinidine—Gastrointestinal disorder—Temozolomide—melanoma	0.000262	0.00198	CcSEcCtD
Quinidine—Feeling abnormal—Carmustine—melanoma	0.000259	0.00195	CcSEcCtD
Quinidine—Asthenia—Bleomycin—melanoma	0.000258	0.00195	CcSEcCtD
Quinidine—Gastrointestinal pain—Carmustine—melanoma	0.000257	0.00194	CcSEcCtD
Quinidine—Immune system disorder—Docetaxel—melanoma	0.000256	0.00194	CcSEcCtD
Quinidine—Mediastinal disorder—Docetaxel—melanoma	0.000256	0.00193	CcSEcCtD
Quinidine—Chills—Docetaxel—melanoma	0.000255	0.00193	CcSEcCtD
Quinidine—Pruritus—Bleomycin—melanoma	0.000254	0.00192	CcSEcCtD
Quinidine—Feeling abnormal—Temozolomide—melanoma	0.00025	0.00189	CcSEcCtD
Quinidine—Mental disorder—Docetaxel—melanoma	0.000249	0.00188	CcSEcCtD
Quinidine—Body temperature increased—Carmustine—melanoma	0.000248	0.00188	CcSEcCtD
Quinidine—Abdominal pain—Carmustine—melanoma	0.000248	0.00188	CcSEcCtD
Quinidine—Gastrointestinal pain—Temozolomide—melanoma	0.000248	0.00187	CcSEcCtD
Quinidine—Erythema—Docetaxel—melanoma	0.000247	0.00187	CcSEcCtD
Quinidine—Malnutrition—Docetaxel—melanoma	0.000247	0.00187	CcSEcCtD
Quinidine—Hypersensitivity—Dactinomycin—melanoma	0.000247	0.00187	CcSEcCtD
Quinidine—CYP1A1—skin epidermis—melanoma	0.000242	0.0537	CbGeAlD
Quinidine—Urticaria—Temozolomide—melanoma	0.000241	0.00182	CcSEcCtD
Quinidine—Asthenia—Dactinomycin—melanoma	0.000241	0.00182	CcSEcCtD
Quinidine—Abdominal pain—Temozolomide—melanoma	0.00024	0.00181	CcSEcCtD
Quinidine—Body temperature increased—Temozolomide—melanoma	0.00024	0.00181	CcSEcCtD
Quinidine—Hypersensitivity—Carmustine—melanoma	0.000231	0.00175	CcSEcCtD
Quinidine—Diarrhoea—Dactinomycin—melanoma	0.000229	0.00173	CcSEcCtD
Quinidine—Vomiting—Bleomycin—melanoma	0.000229	0.00173	CcSEcCtD
Quinidine—Rash—Bleomycin—melanoma	0.000227	0.00171	CcSEcCtD
Quinidine—Dermatitis—Bleomycin—melanoma	0.000226	0.00171	CcSEcCtD
Quinidine—Asthenia—Carmustine—melanoma	0.000225	0.0017	CcSEcCtD
Quinidine—Hypersensitivity—Temozolomide—melanoma	0.000223	0.00169	CcSEcCtD
Quinidine—Syncope—Docetaxel—melanoma	0.000222	0.00167	CcSEcCtD
Quinidine—Leukopenia—Docetaxel—melanoma	0.000221	0.00167	CcSEcCtD
Quinidine—KCNK1—mammalian vulva—melanoma	0.00022	0.0489	CbGeAlD
Quinidine—Palpitations—Docetaxel—melanoma	0.000218	0.00165	CcSEcCtD
Quinidine—Asthenia—Temozolomide—melanoma	0.000218	0.00164	CcSEcCtD
Quinidine—Loss of consciousness—Docetaxel—melanoma	0.000217	0.00164	CcSEcCtD
Quinidine—Diarrhoea—Carmustine—melanoma	0.000215	0.00162	CcSEcCtD
Quinidine—Pruritus—Temozolomide—melanoma	0.000215	0.00162	CcSEcCtD
Quinidine—Convulsion—Docetaxel—melanoma	0.000214	0.00162	CcSEcCtD
Quinidine—Nausea—Bleomycin—melanoma	0.000214	0.00161	CcSEcCtD
Quinidine—Vomiting—Dactinomycin—melanoma	0.000213	0.00161	CcSEcCtD
Quinidine—Rash—Dactinomycin—melanoma	0.000211	0.0016	CcSEcCtD
Quinidine—Myalgia—Docetaxel—melanoma	0.00021	0.00159	CcSEcCtD
Quinidine—Chest pain—Docetaxel—melanoma	0.00021	0.00159	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000209	0.00158	CcSEcCtD
Quinidine—Dizziness—Carmustine—melanoma	0.000208	0.00157	CcSEcCtD
Quinidine—Diarrhoea—Temozolomide—melanoma	0.000208	0.00157	CcSEcCtD
Quinidine—Confusional state—Docetaxel—melanoma	0.000203	0.00154	CcSEcCtD
Quinidine—Oedema—Docetaxel—melanoma	0.000202	0.00152	CcSEcCtD
Quinidine—Dizziness—Temozolomide—melanoma	0.000201	0.00152	CcSEcCtD
Quinidine—Vomiting—Carmustine—melanoma	0.0002	0.00151	CcSEcCtD
Quinidine—Nausea—Dactinomycin—melanoma	0.000199	0.00151	CcSEcCtD
Quinidine—Shock—Docetaxel—melanoma	0.000198	0.0015	CcSEcCtD
Quinidine—Rash—Carmustine—melanoma	0.000198	0.0015	CcSEcCtD
Quinidine—Nervous system disorder—Docetaxel—melanoma	0.000198	0.00149	CcSEcCtD
Quinidine—Dermatitis—Carmustine—melanoma	0.000198	0.00149	CcSEcCtD
Quinidine—Thrombocytopenia—Docetaxel—melanoma	0.000197	0.00149	CcSEcCtD
Quinidine—Tachycardia—Docetaxel—melanoma	0.000197	0.00149	CcSEcCtD
Quinidine—Headache—Carmustine—melanoma	0.000197	0.00149	CcSEcCtD
Quinidine—Skin disorder—Docetaxel—melanoma	0.000196	0.00148	CcSEcCtD
Quinidine—SLC22A4—neck—melanoma	0.000196	0.0435	CbGeAlD
Quinidine—Vomiting—Temozolomide—melanoma	0.000193	0.00146	CcSEcCtD
Quinidine—Anorexia—Docetaxel—melanoma	0.000192	0.00145	CcSEcCtD
Quinidine—Rash—Temozolomide—melanoma	0.000191	0.00145	CcSEcCtD
Quinidine—Dermatitis—Temozolomide—melanoma	0.000191	0.00144	CcSEcCtD
Quinidine—Headache—Temozolomide—melanoma	0.00019	0.00144	CcSEcCtD
Quinidine—Hypotension—Docetaxel—melanoma	0.000188	0.00142	CcSEcCtD
Quinidine—Nausea—Carmustine—melanoma	0.000186	0.00141	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000184	0.00139	CcSEcCtD
Quinidine—Nausea—Temozolomide—melanoma	0.00018	0.00136	CcSEcCtD
Quinidine—Dyspnoea—Docetaxel—melanoma	0.00018	0.00136	CcSEcCtD
Quinidine—Decreased appetite—Docetaxel—melanoma	0.000175	0.00133	CcSEcCtD
Quinidine—Gastrointestinal disorder—Docetaxel—melanoma	0.000174	0.00132	CcSEcCtD
Quinidine—Feeling abnormal—Docetaxel—melanoma	0.000166	0.00126	CcSEcCtD
Quinidine—Gastrointestinal pain—Docetaxel—melanoma	0.000165	0.00125	CcSEcCtD
Quinidine—Body temperature increased—Docetaxel—melanoma	0.000159	0.0012	CcSEcCtD
Quinidine—Abdominal pain—Docetaxel—melanoma	0.000159	0.0012	CcSEcCtD
Quinidine—KCNK1—head—melanoma	0.000158	0.035	CbGeAlD
Quinidine—Hypersensitivity—Docetaxel—melanoma	0.000149	0.00112	CcSEcCtD
Quinidine—Asthenia—Docetaxel—melanoma	0.000145	0.00109	CcSEcCtD
Quinidine—Pruritus—Docetaxel—melanoma	0.000143	0.00108	CcSEcCtD
Quinidine—Diarrhoea—Docetaxel—melanoma	0.000138	0.00104	CcSEcCtD
Quinidine—Dizziness—Docetaxel—melanoma	0.000133	0.00101	CcSEcCtD
Quinidine—Vomiting—Docetaxel—melanoma	0.000128	0.000969	CcSEcCtD
Quinidine—SLC22A8—eye—melanoma	0.000128	0.0283	CbGeAlD
Quinidine—Rash—Docetaxel—melanoma	0.000127	0.000961	CcSEcCtD
Quinidine—Dermatitis—Docetaxel—melanoma	0.000127	0.00096	CcSEcCtD
Quinidine—Headache—Docetaxel—melanoma	0.000126	0.000955	CcSEcCtD
Quinidine—Nausea—Docetaxel—melanoma	0.00012	0.000905	CcSEcCtD
Quinidine—SCN1A—head—melanoma	0.000117	0.026	CbGeAlD
Quinidine—KCNK1—lymph node—melanoma	0.00011	0.0245	CbGeAlD
Quinidine—SCN2A—head—melanoma	0.000107	0.0239	CbGeAlD
Quinidine—SLC22A5—retina—melanoma	9.56e-05	0.0212	CbGeAlD
Quinidine—SCN3A—head—melanoma	9.45e-05	0.021	CbGeAlD
Quinidine—SCN5A—head—melanoma	9.42e-05	0.0209	CbGeAlD
Quinidine—ABCB1—blood vessel—melanoma	8.41e-05	0.0187	CbGeAlD
Quinidine—SLC22A5—skin of body—melanoma	8.39e-05	0.0186	CbGeAlD
Quinidine—CHRM2—head—melanoma	8.02e-05	0.0178	CbGeAlD
Quinidine—SLC22A1—head—melanoma	7.88e-05	0.0175	CbGeAlD
Quinidine—SLCO1A2—head—melanoma	7.58e-05	0.0168	CbGeAlD
Quinidine—CYP1A1—skin of body—melanoma	7.5e-05	0.0166	CbGeAlD
Quinidine—CYP2B6—skin of body—melanoma	7.28e-05	0.0162	CbGeAlD
Quinidine—SLC22A8—head—melanoma	7.24e-05	0.0161	CbGeAlD
Quinidine—CYP1A1—mammalian vulva—melanoma	6.84e-05	0.0152	CbGeAlD
Quinidine—SCN3A—lymph node—melanoma	6.61e-05	0.0147	CbGeAlD
Quinidine—ORM1—lymph node—melanoma	6.02e-05	0.0134	CbGeAlD
Quinidine—SLC22A4—lymph node—melanoma	5.79e-05	0.0129	CbGeAlD
Quinidine—KCNH2—head—melanoma	5.79e-05	0.0129	CbGeAlD
Quinidine—ABCC2—lymph node—melanoma	4.95e-05	0.011	CbGeAlD
Quinidine—CYP1A1—head—melanoma	4.89e-05	0.0109	CbGeAlD
Quinidine—CYP2B6—head—melanoma	4.75e-05	0.0105	CbGeAlD
Quinidine—CYP2E1—head—melanoma	4.46e-05	0.0099	CbGeAlD
Quinidine—ABCB1—retina—melanoma	4.44e-05	0.00984	CbGeAlD
Quinidine—KCNH2—lymph node—melanoma	4.06e-05	0.009	CbGeAlD
Quinidine—SLC22A5—lymph node—melanoma	3.83e-05	0.00851	CbGeAlD
Quinidine—ABCB1—mammalian vulva—melanoma	3.55e-05	0.00788	CbGeAlD
Quinidine—CYP2D6—head—melanoma	3.53e-05	0.00784	CbGeAlD
Quinidine—CYP1A1—lymph node—melanoma	3.42e-05	0.0076	CbGeAlD
Quinidine—ABCB1—head—melanoma	2.54e-05	0.00564	CbGeAlD
Quinidine—ABCB1—lymph node—melanoma	1.78e-05	0.00395	CbGeAlD
Quinidine—SLC22A2—Metabolism—PPARG—melanoma	5.83e-06	4.57e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GNA11—melanoma	5.83e-06	4.57e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CD44—melanoma	5.8e-06	4.54e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GNAQ—melanoma	5.8e-06	4.54e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CD—melanoma	5.79e-06	4.54e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—FASN—melanoma	5.75e-06	4.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CSF2—melanoma	5.73e-06	4.49e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGF1—melanoma	5.73e-06	4.49e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ABCB1—melanoma	5.73e-06	4.49e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—ALB—melanoma	5.72e-06	4.48e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PRKCA—melanoma	5.71e-06	4.48e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.71e-06	4.47e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—FASN—melanoma	5.7e-06	4.47e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ERCC2—melanoma	5.66e-06	4.44e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SLC5A5—melanoma	5.66e-06	4.43e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL2—melanoma	5.65e-06	4.43e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.63e-06	4.41e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CG—melanoma	5.63e-06	4.41e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—E2F1—melanoma	5.61e-06	4.4e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SLC5A5—melanoma	5.61e-06	4.4e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PRKCA—melanoma	5.59e-06	4.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CB—melanoma	5.58e-06	4.38e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP1B1—melanoma	5.56e-06	4.36e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PDGFRA—melanoma	5.55e-06	4.35e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ERCC2—melanoma	5.55e-06	4.35e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ITGB3—melanoma	5.5e-06	4.31e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PRKCA—melanoma	5.5e-06	4.31e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GNAQ—melanoma	5.46e-06	4.28e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CD44—melanoma	5.46e-06	4.28e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—melanoma	5.43e-06	4.26e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GNAQ—melanoma	5.42e-06	4.25e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CD44—melanoma	5.42e-06	4.25e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SPP1—melanoma	5.39e-06	4.23e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAP2K2—melanoma	5.37e-06	4.21e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PLA2G6—melanoma	5.37e-06	4.21e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—melanoma	5.37e-06	4.21e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CD—melanoma	5.32e-06	4.17e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CD—melanoma	5.31e-06	4.16e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.3e-06	4.16e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PRKCA—melanoma	5.27e-06	4.13e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP17A1—melanoma	5.27e-06	4.13e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.25e-06	4.12e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ABCB1—melanoma	5.25e-06	4.12e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ALB—melanoma	5.25e-06	4.11e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ALB—melanoma	5.24e-06	4.11e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP1B1—melanoma	5.24e-06	4.11e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ERCC2—melanoma	5.23e-06	4.1e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.2e-06	4.08e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP1B1—melanoma	5.19e-06	4.07e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	5.13e-06	4.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2—melanoma	5.13e-06	4.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—melanoma	5.11e-06	4.01e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—melanoma	5.1e-06	4e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RAC1—melanoma	5.1e-06	3.99e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CB—melanoma	5.05e-06	3.96e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—melanoma	5e-06	3.92e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GNA11—melanoma	4.98e-06	3.9e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CD—melanoma	4.95e-06	3.88e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HIF1A—melanoma	4.89e-06	3.83e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ALB—melanoma	4.88e-06	3.83e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—FASN—melanoma	4.87e-06	3.82e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PRKCA—melanoma	4.83e-06	3.79e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—VCAN—melanoma	4.82e-06	3.78e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ERCC2—melanoma	4.79e-06	3.76e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SLC5A5—melanoma	4.79e-06	3.76e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KDR—melanoma	4.67e-06	3.66e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CB—melanoma	4.63e-06	3.63e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CD44—melanoma	4.63e-06	3.63e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GNAQ—melanoma	4.63e-06	3.63e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CB—melanoma	4.63e-06	3.63e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—melanoma	4.59e-06	3.6e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—melanoma	4.58e-06	3.59e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.58e-06	3.59e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.53e-06	3.55e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FN1—melanoma	4.5e-06	3.53e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.49e-06	3.52e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—melanoma	4.47e-06	3.51e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP1B1—melanoma	4.44e-06	3.48e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOTCH1—melanoma	4.4e-06	3.45e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—melanoma	4.38e-06	3.43e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—melanoma	4.36e-06	3.42e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.33e-06	3.4e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—melanoma	4.32e-06	3.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CD80—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CB—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ABCB1—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CA—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APC—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KIT—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—NRAS—melanoma	4.31e-06	3.38e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ABCB1—melanoma	4.28e-06	3.35e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—melanoma	4.27e-06	3.35e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGF—melanoma	4.26e-06	3.34e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—melanoma	4.23e-06	3.31e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PRKCA—melanoma	4.21e-06	3.3e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ERCC2—melanoma	4.18e-06	3.27e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—melanoma	4.13e-06	3.24e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK3—melanoma	4.12e-06	3.23e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP17A1—melanoma	4.07e-06	3.19e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BRAF—melanoma	4.05e-06	3.17e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—melanoma	4e-06	3.14e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—melanoma	4e-06	3.13e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—melanoma	3.99e-06	3.13e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.97e-06	3.11e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PRKCA—melanoma	3.97e-06	3.11e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IGF1—melanoma	3.94e-06	3.09e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ERCC2—melanoma	3.94e-06	3.09e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PRKCA—melanoma	3.93e-06	3.08e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CD—melanoma	3.93e-06	3.08e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK1—melanoma	3.92e-06	3.08e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—melanoma	3.92e-06	3.08e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.92e-06	3.07e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ERCC2—melanoma	3.9e-06	3.06e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ALB—melanoma	3.88e-06	3.04e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CD—melanoma	3.85e-06	3.02e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GNA11—melanoma	3.84e-06	3.01e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAP2K1—melanoma	3.81e-06	2.99e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ALB—melanoma	3.8e-06	2.98e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—melanoma	3.79e-06	2.97e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CD—melanoma	3.78e-06	2.97e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—FASN—melanoma	3.76e-06	2.95e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	3.75e-06	2.94e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—melanoma	3.73e-06	2.92e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—melanoma	3.71e-06	2.9e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC5A5—melanoma	3.7e-06	2.9e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—melanoma	3.65e-06	2.87e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ABCB1—melanoma	3.65e-06	2.86e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CD—melanoma	3.63e-06	2.85e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGF2—melanoma	3.62e-06	2.84e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CA—melanoma	3.6e-06	2.82e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ALB—melanoma	3.58e-06	2.81e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GNAQ—melanoma	3.57e-06	2.8e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CD44—melanoma	3.57e-06	2.8e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—melanoma	3.52e-06	2.76e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CB—melanoma	3.43e-06	2.69e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP1B1—melanoma	3.42e-06	2.68e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	3.4e-06	2.67e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—melanoma	3.4e-06	2.66e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MDM2—melanoma	3.39e-06	2.66e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PRKCA—melanoma	3.36e-06	2.64e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CB—melanoma	3.36e-06	2.63e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ERBB2—melanoma	3.34e-06	2.62e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ERCC2—melanoma	3.33e-06	2.61e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CD—melanoma	3.33e-06	2.61e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—melanoma	3.33e-06	2.61e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—melanoma	3.3e-06	2.59e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CB—melanoma	3.3e-06	2.59e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ALB—melanoma	3.29e-06	2.58e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.23e-06	2.53e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—melanoma	3.18e-06	2.5e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—melanoma	3.17e-06	2.49e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CB—melanoma	3.16e-06	2.48e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HRAS—melanoma	3.15e-06	2.47e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—melanoma	3.14e-06	2.46e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—melanoma	3.11e-06	2.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1B—melanoma	3.1e-06	2.43e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—melanoma	3.08e-06	2.42e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CA—melanoma	3.08e-06	2.41e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—melanoma	3.06e-06	2.4e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—melanoma	3.03e-06	2.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—melanoma	3.03e-06	2.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—melanoma	3.01e-06	2.36e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—melanoma	3e-06	2.35e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—melanoma	2.97e-06	2.33e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—melanoma	2.96e-06	2.32e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—melanoma	2.95e-06	2.32e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—melanoma	2.94e-06	2.31e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CTNNB1—melanoma	2.92e-06	2.29e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CB—melanoma	2.9e-06	2.27e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—melanoma	2.9e-06	2.27e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CD—melanoma	2.9e-06	2.27e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—melanoma	2.88e-06	2.25e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—melanoma	2.87e-06	2.25e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ALB—melanoma	2.86e-06	2.24e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1A—melanoma	2.86e-06	2.24e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—melanoma	2.85e-06	2.23e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NFKB1—melanoma	2.84e-06	2.22e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CA—melanoma	2.83e-06	2.21e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CA—melanoma	2.82e-06	2.21e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ABCB1—melanoma	2.82e-06	2.21e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—melanoma	2.78e-06	2.18e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.76e-06	2.17e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—melanoma	2.73e-06	2.14e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CD—melanoma	2.73e-06	2.14e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CD—melanoma	2.71e-06	2.12e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ALB—melanoma	2.7e-06	2.12e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ALB—melanoma	2.67e-06	2.1e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—melanoma	2.63e-06	2.06e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CA—melanoma	2.63e-06	2.06e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PRKCA—melanoma	2.59e-06	2.03e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—melanoma	2.57e-06	2.02e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ERCC2—melanoma	2.57e-06	2.02e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—melanoma	2.55e-06	2e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NRAS—melanoma	2.54e-06	1.99e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—melanoma	2.54e-06	1.99e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CB—melanoma	2.53e-06	1.98e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—melanoma	2.51e-06	1.97e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—melanoma	2.51e-06	1.97e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—melanoma	2.5e-06	1.96e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK3—melanoma	2.44e-06	1.91e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CB—melanoma	2.38e-06	1.87e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—melanoma	2.37e-06	1.86e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CB—melanoma	2.36e-06	1.85e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—melanoma	2.36e-06	1.85e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—melanoma	2.34e-06	1.83e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK1—melanoma	2.32e-06	1.82e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—melanoma	2.32e-06	1.82e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CD—melanoma	2.32e-06	1.82e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—melanoma	2.31e-06	1.81e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—melanoma	2.3e-06	1.81e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ALB—melanoma	2.29e-06	1.79e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—melanoma	2.19e-06	1.72e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—melanoma	2.18e-06	1.71e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—melanoma	2.15e-06	1.68e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CA—melanoma	2.09e-06	1.64e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—melanoma	2.06e-06	1.61e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CA—melanoma	2.05e-06	1.6e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—melanoma	2.04e-06	1.6e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—melanoma	2.03e-06	1.59e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CB—melanoma	2.02e-06	1.58e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.01e-06	1.58e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—melanoma	2e-06	1.57e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—melanoma	1.96e-06	1.54e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—melanoma	1.95e-06	1.53e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CA—melanoma	1.93e-06	1.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HRAS—melanoma	1.86e-06	1.46e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CD—melanoma	1.79e-06	1.4e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—melanoma	1.78e-06	1.4e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CA—melanoma	1.77e-06	1.39e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALB—melanoma	1.76e-06	1.38e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—melanoma	1.74e-06	1.37e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—melanoma	1.71e-06	1.34e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—melanoma	1.67e-06	1.31e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—melanoma	1.64e-06	1.29e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—melanoma	1.58e-06	1.24e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CB—melanoma	1.56e-06	1.22e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—melanoma	1.54e-06	1.21e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CA—melanoma	1.54e-06	1.21e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CA—melanoma	1.45e-06	1.14e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—melanoma	1.45e-06	1.13e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CA—melanoma	1.44e-06	1.13e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—melanoma	1.35e-06	1.06e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—melanoma	1.26e-06	9.87e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CA—melanoma	1.23e-06	9.64e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—melanoma	1.19e-06	9.3e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—melanoma	1.18e-06	9.22e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—melanoma	1e-06	7.88e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CA—melanoma	9.49e-07	7.44e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—melanoma	7.76e-07	6.08e-06	CbGpPWpGaD
